Frequent and distinct aberrations of DNA methylation patterns in fibrolamellar carcinoma of the liver

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Tränkenschuh, Wolfgang ^a   Puls, Florian ^a   Christgen, Matthias ^a   Albat, Cord ^a   Heim, Albert ^a   Poczkaj, Jeanette ^a   Fleming, Peer ^a,b   Kreipe, Hans ^a   Lehmann, Ulrich ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Institute of Pathology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; CYCLIN D2; GLUTATHIONE TRANSFERASE P1; MICRORNA; MICRORNA 9 1; MICRORNA 9 2; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; UNCLASSIFIED DRUG; UVOMORULIN;

ADOLESCENT; ADULT; ARTICLE; CANCER GENETICS; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CELL TYPE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; FIBROLAMELLAR CARCINOMA; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER HISTOLOGY; MALE; PYROSEQUENCING; QUANTITATIVE ANALYSIS; AGED; CASE CONTROL STUDY; GENETICS; LIVER TUMOR; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DNA METHYLATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 78149440667     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013688     Document Type: Article

References (31)

1. Baylin SB (2005) DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2 Suppl 1: S4-S11.
2. Chan AO, Rashid A (2006) CpG island methylation in precursors of gastrointestinal malignancies. Curr Mol Med 6: 401-408.
3. Grady WM, Carethers JM (2008) Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 135: 1079-1099.
4. Laird PW (2003) The power and the promise of DNA methylation markers. Nat Rev Cancer 3: 253-266.
5. Huang J (2009) Current progress in epigenetic research for hepatocarcinoma-genesis. Sci China C Life Sci 52: 31-42.
6. Lehmann U, Berg-Ribbe I, Wingen LU, Brakensiek K, Becker T (2005) Distinct methylation patterns of benign and malignant liver tumors revealed by quantitative methylation profiling. Clin Cancer Res 11: 3654-3660.
7. Liu S, Chan KW, Wang B, Qiao L (2009) Fibrolamellar hepatocellular carcinoma. Am J Gastroenterol 104: 2617-2624.
8. Torbenson M (2007) Review of the clinicopathologic features of fibrolamellar carcinoma. Adv Anat Pathol 14: 217-223.
9. Wilkens L, Bredt M, Flemming P, Kubicka S, Klempnauer J, et al. (2000) Cytogenetic aberrations in primary and recurrent fibrolamellar hepatocellular carcinoma detected by comparative genomic hybridization. Am J Clin Pathol 114: 867-874.
10. Kakar S, Chen X, Ho C, Burgart LJ, Sahai V, et al. (2009) Chromosomal changes in fibrolamellar hepatocellular carcinoma detected by array comparative genomic hybridization. Mod Pathol 22: 134-141.
11. Ehrlich M (2006) Cancer-linked DNA hypomethylation and its relationship to hypermethylation. Curr Top Microbiol Immunol 310: 251-274.
12. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, et al. (2004) A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 32: e38.
13. Schagdarsurengin U, Wilkens L, Steinemann D, Flemming P, Kreipe HH, et al. (2003) Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Oncogene 22: 1866-1871.
14. Pfeifer GP, Yoon JH, Liu L, Tommasi S, Wilczynski SP, et al. (2002) Methylation of the RASSF1A gene in human cancers. Biol Chem 383: 907-914.
15. Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, et al. (2007) Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 67: 1424-1429.
16. Lehmann U, Hasemeier B, Christgen M, Muller M, Romermann D, et al. (2008) Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 214: 17-24.
17. Agirre X, Vilas-Zornoza A, Jimenez-Velasco A, Martin-Subero JI, Cordeu L, et al. (2009) Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. Cancer Res 69: 4443-4453.
18. Bueno MJ, Perez de Castro I, Gomez de Cedron M, Santos J, Calin GA, et al. (2008) Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13: 496-506.
19. Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, et al. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 68: 5049-5058.
20. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, et al. (2010) miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepato-cellular carcinoma. Carcinogenesis 31: 766-776.
21. De Smet C, Loriot A (2010) DNA hypomethylation in cancer: Epigenetic scars of a neoplastic journey. Epigenetics 5(3).
22. Lee HS, Kim BH, Cho NY, Yoo EJ, Choi M, et al. (2009) Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma. Clin Cancer Res 15: 812-820.
23. Cho NY, Kim JH, Moon KC, Kang GH (2009) Genomic hypomethylation and CpG island hypermethylation in prostatic intraepithelial neoplasm. Virchows Arch 454: 17-23.
24. Park SY, Yoo EJ, Cho NY, Kim N, Kang GH (2009) Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection. J Pathol 219: 410-416.
25. Kim MJ, White-Cross JA, Shen L, Issa JP, Rashid A (2009) Hypomethylation of long interspersed nuclear element-1 in hepatocellular carcinomas. Mod Pathol 22: 442-449.
26. Dakubo GD, Jakupciak JP, Birch-Machin MA, Parr RL (2007) Clinical implications and utility of field cancerization. Cancer Cell Int 7: 2.
27. Vivekanandan P, Torbenson M (2008) Epigenetic instability is rare in fibrolamellar carcinomas but common in viral-associated hepatocellular carcinomas. Mod Pathol 21: 670-675.ss
28. Brakensiek K, Langer F, Kreipe H, Lehmann U (2004) Low level of DAP-kinase DNA methylation in myelodysplastic syndrome. Blood 104: 1586-1587.
29. Lee ES, Issa JP, Roberts DB, Williams MD, Weber RS, et al. (2008) Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance. Clin Cancer Res 14: 2664-2672.
30. Colella S, Shen L, Baggerly KA, Issa JP, Krahe R (2003) Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. Biotechniques 35: 146-150.
31. Simon R, Lam A, Li MC, Ngan M, Menenzes S, et al. (2007) Analysis of Gene Expression Data Using BRB-Array Tools. Cancer Inform 3: 11-17.